Cardiff Park Advisors, LLC Gsk PLC Transaction History

Cardiff Park Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$16.13 - $44.61 $42,712 - $118,127	-2,648 Reduced 19.39%	11,008 $324,000
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $7,232 - $8,216	172 Added 1.28%	13,656 $594,000
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $5,994 - $7,113	149 Added 1.12%	13,484 $587,000
Q4 2021 Feb 15, 2022	BUY	$38.88 - $45.31 $518,464 - $604,208	13,335 New	13,335 $588,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cardiff Park Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cardiff Park Advisors, LLC with notifications on news.